The "Tumour Targeting, Imaging, Radiotherapies" network of the Cancéropôle Grand-Ouest is pleased to announce its eighteenth international workshop dedicated to young researchers (PhD students and post-docs), even so experienced researchers are invited to participate.
The 18th edition of
“Tumour targeting, Imaging, Radiotherapies” workshop
will be held
in Erquy, West of France.
The main objective of this international workshop is to confront the points of view and issues of various research fields such as
Chemistry, Biology, Physics, Medicine, Computer science, involved in the
development of molecular and external beam radiotherapies in Oncology.
In 2025, the focus will be on poor prognosis cancers, which remain a major priority for cancer research. The workshop will highlight how combination treatments and therapeutic associations open up new perspectives. Particular attention will also be given to innovative technologies: Artificial Intelligence to improve radiotherapy dosimetry, the development of new biological targets, and key topics in external beam radiotherapy such as high-dose-rate radiotherapy.
Presentations of biologists, chemists, physicists, computer scientists and physicians will cover advances in this field of cancer research.
30 travel grant awards are available for young researchers (PhD students and post-docs).
Invited speakers in 2025:
- Michel Koole, Associate Professor, Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
- Ahmed Idbaih, Professor, Neuro-Oncologist, Sorbonne University, Institut du Cerveau, ICM, AP-HP, Hôpitaux
Universitaires La Pitié Salpêtrière-Charles Foix, Neurology service, Paris, France.
- Anna Lucia Tornesello, Researcher, Innovative Immunological Models Unit, Istituto
Nazionale Tumori IRCCS, Napoli, Italy.
- Charlotte Robert, Associate Professor, Molecular radiotherapy unit, Inserm, Gustave
Roussy, University of Paris –Sud, Paris, France.
- Yan Rolland, Interventional Radiologist, LTSI, Laboratoire Traitement du Signal et de l'Image, Centre
Eugène Marquis, Rennes, France.
- Audrey Bouchet, Researcher, "Radiations, Défense, Santé, Environnement" team, IDEE Epilepsy Institute,
Groupement Hospitalier Est-HCL, Lyon, France.
The workshop will be built around lectures from the invited expert speakers and thematic sessions with selected oral presentations from young researchers providing valuable opportunities for discussion on innovative issues and highlighting integration among several disciplines.
This workshop aims at sharing scientific results and at facilitating exchanges between experienced and young researchers in the fast-growing field of imaging and radiotherapies.
In order to stimulate intense discussions between young and senior scientists, total attendance is limited to a maximum of 65 participants.
What is the "Tumour Targeting, Imaging, Radiotherapies" network of the Canceropôle Grand Ouest ?
The first "Plan Cancer" was launched in 2003 as an initiative to foster France's efforts in cancer management. One of the actions of the plan was the creation of 7 "Cancéropôles" with the mission of organizing cooperation in the field of translational research between laboratories and clinical departments within a geographic area. Thus the Cancéropôle Grand Ouest (CGO) was set-up, covering 3 of the 13 French Regions.
The CGO is now organized in 8 networks.
The "Tumour Targeting, Imaging, Radiotherapies" network includes four interconnected research domains, which are:
- Concept of innovating agents and nanomedicines for imaging and therapeutic purposes,
- Targeted therapies and radiotherapies for cancer: from animal models to clinical trials,
- Quantitative multimodal imaging and radiotherapies,
- Biological response and radiotherapies.
This network is coordinated by Dimitris Visvikis, LaTIM, National Institute of Health & Clinical Sciences, Brest, France.
More information : http://www.canceropole-grandouest.com
